314 related articles for article (PubMed ID: 26369878)
1. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
[TBL] [Abstract][Full Text] [Related]
2. Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice.
Wang Z; Zhang D; Cheng C; Lin Z; Zhou D; Sun Y; Li W; Yan J; Luo S; Qian Z; Li Z; Huang G
Nutrients; 2023 Oct; 15(19):. PubMed ID: 37836528
[TBL] [Abstract][Full Text] [Related]
3. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
[TBL] [Abstract][Full Text] [Related]
4. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
[TBL] [Abstract][Full Text] [Related]
5. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.
Chung E; Ji Y; Sun Y; Kascsak RJ; Kascsak RB; Mehta PD; Strittmatter SM; Wisniewski T
BMC Neurosci; 2010 Oct; 11():130. PubMed ID: 20946660
[TBL] [Abstract][Full Text] [Related]
6. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
[TBL] [Abstract][Full Text] [Related]
7. Effects of an amyloid-beta 1-42 oligomers antibody screened from a phage display library in APP/PS1 transgenic mice.
Wang J; Li N; Ma J; Gu Z; Yu L; Fu X; Liu X; Wang J
Brain Res; 2016 Mar; 1635():169-79. PubMed ID: 26820640
[TBL] [Abstract][Full Text] [Related]
8. Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease.
Takeda S; Hashimoto T; Roe AD; Hori Y; Spires-Jones TL; Hyman BT
FASEB J; 2013 Aug; 27(8):3239-48. PubMed ID: 23640054
[TBL] [Abstract][Full Text] [Related]
9. Exercise combined with postbiotics treatment results in synergistic improvement of mitochondrial function in the brain of male transgenic mice for Alzheimer's disease.
Kolonics A; Bori Z; Torma F; Abraham D; Fehér J; Radak Z
BMC Neurosci; 2023 Dec; 24(1):68. PubMed ID: 38110905
[TBL] [Abstract][Full Text] [Related]
10. Rescue of cognitive deficits in APP/PS1 mice by accelerating the aggregation of β-amyloid peptide.
Zhang JX; Lai YH; Mi PY; Dai XL; Zhang R; Zhang ZJ; Zhang SJ; Zhang XW; Zhang XY; Yang BY; Cui DM; Zhang C; Zhao CQ; Dou F
Alzheimers Res Ther; 2019 Dec; 11(1):106. PubMed ID: 31847879
[TBL] [Abstract][Full Text] [Related]
11. Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology.
Readhead B; Haure-Mirande JV; Zhang B; Haroutunian V; Gandy S; Schadt EE; Dudley JT; Ehrlich ME
Mol Psychiatry; 2016 Aug; 21(8):1099-111. PubMed ID: 26552589
[TBL] [Abstract][Full Text] [Related]
12. Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease.
Raefsky SM; Furman R; Milne G; Pollock E; Axelsen P; Mattson MP; Shchepinov MS
Neurobiol Aging; 2018 Jun; 66():165-176. PubMed ID: 29579687
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo.
Hong HS; Rana S; Barrigan L; Shi A; Zhang Y; Zhou F; Jin LW; Hua DH
J Neurochem; 2009 Feb; 108(4):1097-1108. PubMed ID: 19141069
[TBL] [Abstract][Full Text] [Related]
14. Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina.
Carrero L; Antequera D; Alcalde I; Megias D; Ordoñez-Gutierrez L; Gutierrez C; Merayo-Lloves J; Wandosell F; Municio C; Carro E
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958666
[TBL] [Abstract][Full Text] [Related]
15. Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
Tanifum EA; Dasgupta I; Srivastava M; Bhavane RC; Sun L; Berridge J; Pourgarzham H; Kamath R; Espinosa G; Cook SC; Eriksen JL; Annapragada A
PLoS One; 2012; 7(10):e48515. PubMed ID: 23119043
[TBL] [Abstract][Full Text] [Related]
16. Ferulic Acid Ameliorates Alzheimer's Disease-like Pathology and Repairs Cognitive Decline by Preventing Capillary Hypofunction in APP/PS1 Mice.
Wang NY; Li JN; Liu WL; Huang Q; Li WX; Tan YH; Liu F; Song ZH; Wang MY; Xie N; Mao RR; Gan P; Ding YQ; Zhang Z; Shan BC; Chen LD; Zhou QX; Xu L
Neurotherapeutics; 2021 Apr; 18(2):1064-1080. PubMed ID: 33786807
[TBL] [Abstract][Full Text] [Related]
17. Galactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's disease.
Cherry JD; Liu B; Frost JL; Lemere CA; Williams JP; Olschowka JA; O'Banion MK
PLoS One; 2012; 7(12):e53275. PubMed ID: 23300905
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric β-Amyloid Assemblies.
Vrancx C; Vadukul DM; Suelves N; Contino S; D'Auria L; Perrin F; van Pesch V; Hanseeuw B; Quinton L; Kienlen-Campard P
Mol Neurobiol; 2021 Dec; 58(12):6647-6669. PubMed ID: 34608607
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic Acid-Acylated Astaxanthin Monoester Ameliorates Amyloid-β Pathology and Neuronal Damage by Restoring Autophagy in Alzheimer's Disease Models.
Wang X; Song Y; Cong P; Wang Z; Liu Y; Xu J; Xue C
Mol Nutr Food Res; 2024 Jan; 68(2):e2300414. PubMed ID: 37991232
[TBL] [Abstract][Full Text] [Related]
20. Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brain.
Hong W; Wang Z; Liu W; O'Malley TT; Jin M; Willem M; Haass C; Frosch MP; Walsh DM
Acta Neuropathol; 2018 Jul; 136(1):19-40. PubMed ID: 29687257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
